CRIS
Price
$2.16
Change
-$0.14 (-6.09%)
Updated
Jun 20 closing price
Capitalization
22.91M
VTGN
Price
$2.06
Change
-$0.00 (-0.00%)
Updated
Jun 20 closing price
Capitalization
59.92M
Interact to see
Advertisement

CRIS vs VTGN

Header iconCRIS vs VTGN Comparison
Open Charts CRIS vs VTGNBanner chart's image
Curis
Price$2.16
Change-$0.14 (-6.09%)
Volume$66.65K
Capitalization22.91M
VistaGen Therapeutics
Price$2.06
Change-$0.00 (-0.00%)
Volume$396.16K
Capitalization59.92M
CRIS vs VTGN Comparison Chart in %
Loading...
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRIS vs. VTGN commentary
Jun 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRIS is a Hold and VTGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 21, 2025
Stock price -- (CRIS: $2.19 vs. VTGN: $2.06)
Brand notoriety: CRIS and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRIS: 75% vs. VTGN: 262%
Market capitalization -- CRIS: $22.91M vs. VTGN: $59.92M
CRIS [@Biotechnology] is valued at $22.91M. VTGN’s [@Biotechnology] market capitalization is $59.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $333.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRIS’s FA Score shows that 0 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • CRIS’s FA Score: 0 green, 5 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, VTGN is a better buy in the long-term than CRIS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRIS’s TA Score shows that 3 TA indicator(s) are bullish while VTGN’s TA Score has 3 bullish TA indicator(s).

  • CRIS’s TA Score: 3 bullish, 5 bearish.
  • VTGN’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CRIS is a better buy in the short-term than VTGN.

Price Growth

CRIS (@Biotechnology) experienced а -10.61% price change this week, while VTGN (@Biotechnology) price change was -7.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.70%. For the same industry, the average monthly price growth was +28.03%, and the average quarterly price growth was +14.56%.

Reported Earning Dates

CRIS is expected to report earnings on Mar 31, 2025.

VTGN is expected to report earnings on Jun 17, 2025.

Industries' Descriptions

@Biotechnology (+9.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTGN($59.9M) has a higher market cap than CRIS($22.9M). CRIS YTD gains are higher at: -28.431 vs. VTGN (-30.339). CRIS has higher annual earnings (EBITDA): -40.26M vs. VTGN (-52.22M). VTGN has more cash in the bank: 88.6M vs. CRIS (20.3M). VTGN has less debt than CRIS: VTGN (1.71M) vs CRIS (2.64M). CRIS has higher revenues than VTGN: CRIS (11.2M) vs VTGN (698K).
CRISVTGNCRIS / VTGN
Capitalization22.9M59.9M38%
EBITDA-40.26M-52.22M77%
Gain YTD-28.431-30.33994%
P/E RatioN/AN/A-
Revenue11.2M698K1,605%
Total Cash20.3M88.6M23%
Total Debt2.64M1.71M154%
FUNDAMENTALS RATINGS
CRIS vs VTGN: Fundamental Ratings
CRIS
VTGN
OUTLOOK RATING
1..100
8164
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
47
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
6489
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTGN's Valuation (47) in the Biotechnology industry is in the same range as CRIS (63). This means that VTGN’s stock grew similarly to CRIS’s over the last 12 months.

VTGN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CRIS (100). This means that VTGN’s stock grew similarly to CRIS’s over the last 12 months.

VTGN's SMR Rating (97) in the Biotechnology industry is in the same range as CRIS (100). This means that VTGN’s stock grew similarly to CRIS’s over the last 12 months.

CRIS's Price Growth Rating (64) in the Biotechnology industry is in the same range as VTGN (89). This means that CRIS’s stock grew similarly to VTGN’s over the last 12 months.

CRIS's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VTGN (100). This means that CRIS’s stock grew similarly to VTGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRISVTGN
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 11 days ago
75%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RHP98.790.45
+0.46%
Ryman Hospitality Properties
VZ41.700.03
+0.07%
Verizon Communications
LZB38.13-0.15
-0.39%
La-Z-Boy
AURA6.03-0.07
-1.15%
Aura Biosciences
BNGO3.20-0.12
-3.61%
Bionano Genomics Inc

CRIS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRIS has been loosely correlated with ABEO. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CRIS jumps, then ABEO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRIS
1D Price
Change %
CRIS100%
-4.78%
ABEO - CRIS
37%
Loosely correlated
-1.92%
VTGN - CRIS
36%
Loosely correlated
-0.24%
NUVL - CRIS
36%
Loosely correlated
-0.70%
ROIV - CRIS
36%
Loosely correlated
+0.09%
CGON - CRIS
36%
Loosely correlated
-2.78%
More